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Transcriptomics in lung tissue 
upon respiratory syncytial virus 
infection reveals aging as important 
modulator of immune activation 
and matrix maintenance
Jeroen L. A. Pennings  1, Rob Mariman2, Hennie M. Hodemaekers1, Sylvia S. N. Reemers2,3, 
Riny Janssen1 & Teun Guichelaar2
Aging poses an increased risk of severe infection by respiratory syncytial virus (RSV). The many different 
biological pathways comprising the response to infection in lungs that are influenced by aging are 
complex and remain to be defined more thoroughly. Towards finding new directions in research on 
aging, we aimed to define biological pathways in the acute response to RSV that are affected in the 
lungs by aging. We therefore profiled the full transcriptome of lung tissue of mice prior to and during 
RSV infection both at young and old age. In the absence of RSV, we found aging to downregulate genes 
that are involved in constitution of the extracellular matrix. Moreover, uninfected old mice showed 
elevated expression of pathways that resemble injury, metabolic aberrations, and disorders mediated 
by functions of the immune system that were induced at young age only by an exogenous trigger 
like RSV. Furthermore, infection by RSV mounted stronger activation of anti-viral type-I interferon 
pathways at old age. Despite such exaggerated anti-viral responses, old mice showed reduced 
control of virus. Altogether, our findings emphasize important roles in aging-related susceptibility to 
respiratory disease for extracellular matrix dysfunctions and dysregulated immune activation in lungs.
Old age poses an increased risk for severe disease of the airways caused by respiratory syncytial virus (RSV). In 
the elderly population it has been estimated that numbers of hospitalization due to RSV infection may reach close 
to the numbers of respiratory illness caused by influenza viruses1–3. In mice, RSV has been shown to cause more 
lung pathology at old age, but the different mechanisms comprising the response to infection that are influenced 
by aging of the lung tissue largely remain to be defined. Studies on the full transcriptome in young adult mice have 
shown that the response to RSV at the site of infection is complex as it involves many different biological path-
ways4,5. Altered antiviral expression of some genes in lung due to aging6,7 and increased susceptibility to infectious 
diseases indicate the involvement of unique age-related features that should be considered towards understanding 
disease at old age. However, effects of aging on the full RSV-induced transcription profile in lungs have remained 
elusive. In our study, we determined the full transcription profile in the lungs during infection with RSV to pro-
vide a more comprehensive exploration of the consequences of old age on gene expression.
Increased susceptibility to disease caused by RSV in the elderly has largely been ascribed to age-related decline 
of the levels of protective antibodies and memory function of cells of the adaptive immune system resulting in 
insufficient RSV-specific immunity8–11. Infection due to this lack of acquired RSV-specific immunity implies a 
prominent role for direct innate anti-viral immune mechanisms that are activated in infected tissue in order to 
control the virus. A prominent role for innate responses has been exemplified by a study that shows genetic sus-
ceptibility to RSV-induced bronchiolitis in children being predominantly associated with innate immune genes12. 
Moreover, these innate genes comprise pro-inflammatory genes, indicating a prominent role for inflammatory 
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conditions in susceptibility to disease by RSV-infection12. Hence, innate immune responses to RSV do not only 
control the infection but can also induce inflammation that contributes to pathology and is associated with RSV 
bronchiolitis7,12. The importance of the acute responses of the innate immune compartment in disease is also 
underscored by studies in blood of RSV-challenged human adults. These showed that many of the genes that 
discriminate symptomatic individuals from asymptomatic individuals are involved in innate and acute immune 
responses induced by viruses13,14. Altogether, these findings suggest an important role for the acute anti-viral 
response and its resulting inflammation during RSV infection at old age.
The expression of some pro-inflammatory cytokines produced in lungs in response to RSV infection and 
clearance of virus have been reported to be delayed at old age in cotton rat and mouse models6–8. These observa-
tions with respect to RSV are in line with the general view that many of the innate responses that participate in 
defeating pathogens become dysfunctional at old age15,16. Paradoxically, although inflammatory responses that are 
induced via these innate immune mechanisms may be compromised at old age, aging is accompanied by chroni-
cally increased levels of markers of inflammation, a phenomenon that is known as inflammaging17. Such chronic 
inflammation at old age has been observed in lungs of mice in the absence of specified pathogens18. Despite the 
plethora of studies on inflammaging and aging-related alterations of immune responses to RSV, the biological 
pathways of the acute response to RSV in situ in the lungs that are affected by aging are still elusive.
To define the biological pathways in the acute response to RSV that are affected by old age, we determined 
the full transcription profiles of lung tissue of adult mice in the primary response to RSV-infection at young and 
old age. Comparing these primary responses to RSV at young and old age, as well as between uninfected mice of 
both age groups, provide insights into age-related deficiencies in processes that pose increased susceptibility to 
RSV. Moreover, genes and pathways identified by this approach will point towards previously neglected biological 
mechanisms that may be key to RSV-induced pneumonia at old age and direct future research on aging-related 
susceptibility to infectious respiratory diseases.
The BALB/c model is widely used to study responses to RSV in vivo since it reflects the antigen-specific 
Th2-biased pathology in FI-vaccinated children and BALB/c mice have shown relative susceptibility to infection 
with human RSV. According to some studies, this mouse strain is somewhat more permissive to RSV replication 
than the C57BL/6 mice that are often used to study cellular immunity to intracellular antigens19,20. Nonetheless, 
C57BL/6 mice are well suited for studying RSV replication, acute disease and immune responses resulting from 
RSV infection19,21,22. Several studies have shown that levels of replication and disease by human RSV in C57BL/6 
mice can get similar to the levels found in BALB/c mice21,22. We explored the impact of aging in C57BL/6 mice, 
since mice of this strain are widely utilized to study anti-viral cellular responses and provide the background for 
many transgenic and knockout mice used to study immune responses19,23.
Results
We quantified transcription in lung tissue of young and old mice at 2 and 5 days after inoculation with RSV, and 
in lung tissue of non-inoculated young and old mice. For the analysis of RSV-regulated genes we considered the 
genes that were significantly up or downregulated at any of the two time points upon inoculation. We analysed 
dissimilarities between the 6 groups for the combined set of all regulated genes by principal component analysis 
(PCA) (Fig. 1A). This showed a clear separation between all groups. The first principal component (PC1) explains 
57% of all variance and shows differences between age groups under all conditions. Moreover, as illustrated by the 
Venn diagram in Fig. 1B, the young and old groups show both unique and shared up and downregulated genes 
(Fig. 1B).
Functional annotation analysis by DAVID24 of all 373 significantly regulated genes under any of the condi-
tions by age and/or response to RSV at any of the days after inoculation with RSV revealed that several pathways 
and functionalities were overrepresented, which –for further analysis– we grouped into several umbrella catego-
ries. We categorized genes with known immunological functions as innate interferon (IFN)-mediated antiviral 
function (24 genes), cytokines (8 genes), antigen processing and presentation (6 genes), immunoglobulins (10 
genes), or other immune function (18 genes). Also, twenty genes involved in matrix constitution were signifi-
cantly regulated in our study. For the six categories mentioned above, different expression patterns can be recog-
nized (Fig. 2). In addition, 172 genes with known functionalities were annotated by functions other than these 
aforementioned categories. Of all differentially regulated genes, 70 genes were not annotated as having a function 
(‘unknown function’) and 45 genes are only known as gene models based on their sequence, but it is not known 
if they correspond to actual genes or have a functionality. For our further analyses of genes annotated by DAVID, 
we included only the genes that could be categorized by the six functional categories.
Aging regulates gene expression in lungs under basal conditions. Aging itself induces alterations 
in expression of a considerable number of genes as shown by comparison of lungs of non-RSV inoculated mice at 
young and old age (Fig. 1B). Notably, 15 percent of these genes that were regulated by aging in the absence of RSV 
infection were also significantly regulated by RSV in young mice (Fig. 1B), indicating that aging induces biolog-
ical features in lungs that are found at young age only upon exposure to RSV. Thus, aging of lung tissue defines a 
distinctive set of altered gene expressions in steady state.
In the absence of RSV we observed in lungs of old mice a major elevation of expression of immunoglobulin 
genes (J chain, Igkv3-4, Igkv4-59, Igk, Igkv6-23, Igkc, Ighg, Igh-VJ558), compared to lungs of young mice (Table 1). 
Some of these, among which the J chain, showed the highest upregulation of all genes regulated in the study. 
Among the genes we categorized further we observed elevated expression at old age for the cytokine genes Cxcl9 
and Spp1, for a gene involved in antigen processing and presentation (Azgp1), for eight other immune-related 
genes (Cxcr6, Gata3, Sp110, Procr, Cybb, Tnfrsf17, C4b, Cfb), and for two matrix-related genes (Vwc2 and Dmbt1). 
Among the gene expression that was downregulated by aging we found many genes that are involved in matrix 
constitution (Col3a1, Adamts15, Adamts9, Spon2, Col4a1, Tnc, Fbn1, Col1a1, Postn, Adamtsl2, Sparc, Frem1), but 
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only one gene that could be classified by immune function (Lef1). These data indicate that aging leads to elevated 
expression of immunological activity in lungs, and downregulation of genes involved in constitution of the extra-
cellular matrix of lung tissue prior to infection.
Response to RSV in lungs distinctive of young age. The principal component analysis shows dif-
ferences between groups related to the response to RSV by principle component 2 (PC2). Young and old mice 
showed a response to RSV roughly in the same direction and with a similar overall magnitude. Overall, in both 
young and old animals the fold change of gene expression in response to RSV was strongest at two days after virus 
inoculation (Fig. 1A). RSV regulated 109 genes in young mice that were not found to be significantly altered in 
RSV-inoculated lungs at old age (Fig. 1B). As shown in Table 2, we found upregulated expression of cytokine 
genes (Ccl8, Cxcl10, Ccl7, Ccl2, Ltb, Bmp7), genes involved in antigen processing and presentation (B2m, H2-K1, 
Fcgr1, H2-D1, H2-Q4), one gene of the innate antiviral IFN-pathway (Iigp1), and genes involved in other immune 
functions (Saa3, Ctss, Clec7a, Cx3cr1, Ly86). Among the downregulated genes, we found one gene involved in 
matrix (Angptl4) and two genes with immune functions (Nr4a3, Rgcc). All other downregulated genes were 
Figure 1. Distinct effects by aging and RSV on gene expression. Panel A shows each individual animal in a 
principal component analysis (PCA) of the microarray data of lung samples derived at day 0 (mock-inoculated, 
black, n = 4/group), or at day 2 (red, n = 5/group) or day 5 (green, n = 5/group) after inoculation with RSV. 
Aging-regulated expression appears by PC1, RSV-regulated gene expression appears along PC2. Y, young 
(circles); O, old (triangles); M, mock control; R, RSV-inoculated. Panel B shows a Venn-diagram depicting 
numbers of genes that are significantly upregulated (↑), downregulated (↓), or show no significant response 
(−). The three symbols indicate from left to right: response to RSV in young mice, response to RSV in old mice, 
response to aging, respectively.
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annotated by other functionalities than immune or matrix functions (Supplemental Table S1). Some responses 
to RSV were found also at old age (e.g. induction of B2M and other molecules involved in antigen processing 
and presentation) or were even stronger (e.g. Saa3, Cxcl10) in old mice but did not reach significance. These data 
indicate that aging causes loss of responsiveness in different molecular pathways involved in the innate immune 
response to RSV in the lungs.
Notably, of the genes that are regulated by aging only (i.e. without RSV infection), some were also significantly 
regulated by RSV in young mice (Table 3), indicating that aging induces biological features in lungs that are found 
at young age only upon exposure to RSV. Among the downregulated genes we found three adamts-encoding 
genes. Moreover, expressions of a set of genes involved in immune functions that are induced in response to 
RSV at young age were significantly elevated at old age (Cxcl9, Cfb, C4b, Cybb, Gata3). This indicates enhanced 
immunological activity in the lungs at old age that would be induced at young age only by an extrinsic trigger like 
an infection by RSV. This suggests partial anti-viral immune activity that may be involved in protection against 
infection at the time of inoculation with RSV particularly at old age.
Gene expression regulated by RSV in the context of aging. Overall, the principal component analy-
sis indicates that variation of responsiveness to RSV between individuals is larger in the old age group compared 
to the young RSV-inoculated mice (Fig. 1A). This larger variation was also reflected in the pooled standard devi-
ation in gene expression within each group, and shows more intragroup heterogeneity in old mice two and five 
days after inoculation with RSV (Table 4). Moreover, a unique set of genes was upregulated by RSV exclusively at 
old age (Table 5). Most of the upregulated immune-related genes in the RSV inoculated old animals were found in 
the antiviral IFN-pathway (Ifi204, Oas1a, Oas2, Eif2ak2, Oas1g) and only two in other immune pathways (C1rb, 
Dhx58). Some genes, like Plxna2 and Klfl1 were downregulated in response to RSV exclusively at old age, but 
none of these genes were within the six selected categories. These data show that aging promotes responsiveness 
to RSV of a unique set of genes that are not significantly activated by RSV at young age, and a substantial part of 
these genes are involved in innate antiviral IFN-pathways.
Our further analyses defined a unique set of genes that were up and down regulated in response to RSV at 
both young and old age (Table 6). Notably, of all molecules related to immune responsiveness within this unique 
set, only molecules that are part of the innate antiviral IFN pathway were involved. Expressions of these antiviral 
Figure 2. Heatmap showing differentially regulated genes. Map shows significantly upregulated (red) and 
downregulated (blue) genes at day 0 (mock-inoculated), or at day 2 or 5 after inoculation with RSV for all 
individual mice at young or old age, categorized by function.
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molecules were all upregulated and comprised a major part of all RSV regulated genes. Moreover, most of these 
molecules of the innate antiviral IFN pathway were activated more strongly at old age. Altogether, the data indi-
cate that RSV induces a stronger activation of the local innate anti-viral IFN pathway at old age.
Viral loads in lungs show impaired clearance of RSV due to aging. Among the RNA isolated from 
lungs at two and five days after inoculation with RSV we analysed the amount of RSV-transcripts by qPCR to 
determine clearance of the virus over the period in which we performed our arrays (Fig. 3). The amount of 









Jchain 11.85 immunoglobulin Col3a1 −2.32 matrix
Igkv3-4 11.55 immunoglobulin Adamts15 −1.91 matrix
Igkv4-59 11.13 immunoglobulin Adamts9 −1.82 matrix
Igk 5.53 immunoglobulin Spon2 −1.67 matrix
Igkv6-23 3.97 immunoglobulin Col4a1 −1.63 matrix
Igkc 3.11 immunoglobulin Tnc −1.63 matrix
Ighg 2.85 immunoglobulin Fbn1 −1.61 matrix
Igh-VJ558 2.46 immunoglobulin Col1a1 −1.59 matrix
Cxcl9 3.02 cytokine Postn −1.58 matrix
Spp1 1.60 cytokine Adamtsl2 −1.57 matrix
Cxcr6 1.84 immune (other) Sparc −1.55 matrix
Gata3 1.79 immune (other) Frem1 −1.52 matrix
Sp110 1.63 immune (other) Lef1 −1.64 immune (other)
Procr 1.62 immune (other)
Cybb 1.61 immune (other)
Tnfrsf17 1.60 immune (other)
C4b 1.59 immune (other)
Cfb 1.56 immune (other)
Azgp1 1.78 antigen proc&pres
Vwc2 1.68 matrix
Dmbt1 1.57 matrix
Table 1. Gene expression affected by age. Positive values depict fold higher expression, negative values depict 
fold reduction in uninfected old mice compared to uninfected young mice. Antigen proc&pres; antigen 
processing and presentation. Immune (other) indicates genes related to immune-related categories other than 
innate antiviral interferon-mediated functions, antigen processing and presentation, immunoglobulins, or 
cytokines.
Upregulated genes day 2 day 5 Function Downregulated genes day 2 day 5 Function
Saa3 7.52 2.35 immune (other) Angptl4 −4.67 −2.31 matrix
Ctss 1.79 1.60 immune (other) Nr4a3 −3.14 −2.96 immune (other)
Clec7a 1.66 1.60 immune (other) Rgcc −2.70 −2.37 immune (other)
Cx3cr1 1.58 1.51 immune (other)
Ly86 1.56 1.52 immune (other)
Ccl8 2.35 1.72 cytokine
Cxcl10 2.03 1.37 cytokine
Ccl7 1.95 1.25 cytokine
Ccl2 1.80 1.14 cytokine
Ltb 1.53 1.56 cytokine
Bmp7 1.51 1.27 cytokine
Iigp1 2.52 2.14 innate antiviral/IFN
B2m 1.68 1.55 antigen proc&pres
H2-K1 1.62 1.58 antigen proc&pres
Fcgr1 1.61 1.29 antigen proc&pres
H2-D1 1.55 1.43 antigen proc&pres
H2-Q4 1.54 1.44 antigen proc&pres
Table 2. Gene expression affected by RSV at young age only. Positive values depict fold higher expression, 
negative values depict fold reduction in RSV-infected mice compared to young uninfected mice.
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whereas in mock controls no RSV was detected (Ct > 40). This indicates that viral loads in lungs did not differ 
between young and old mice at two days after inoculation. However, viral loads significantly increased further 
until day five only in the old group, leading to significantly higher viral loads in old mice compared to young 
mice. This indicates that the first line of defence of aged mice functions less adequately to control a respiratory 
infection with RSV.
Validation of microarray data. For ten significantly regulated genes, selected from five pathways or 
functions, we performed Q-PCR validation (Supplemental Table S3). Overall, the extent of regulation found by 
Q-PCR correlated well with that found by microarray analysis (Spearman R = 0.92). The magnitude of the up- 
or down-regulation was somewhat larger in the Q-PCR data, with the median difference to the corresponding 
microarray values being 17%. This slightly enhanced effect size in Q-PCR is in agreement with previous find-
ings4. In functional terms, the Q-PCR analyses confirmed the main findings of the microarray analyses, namely: 
stronger activation of anti‐viral type‐I interferon pathways in old mice than in young mice; down-regulation by 
age of genes involved in extracellular matrix; up-regulation of cytokines by old age as well as due to RSV infection; 
as well as the expression pattern found for antigen processing and presentation and other immune functionality.
Predicted upstream regulators and disease-related pathways indicate functional interference 
between aging and anti-viral responses. Next, we aimed to predict which upstream molecules that reg-
ulate the expression of genes we analysed may be affected by aging. Considering the genes that were significantly 
regulated in our arrays as downstream effectors, we applied Ingenuity to predict which molecules may serve as 
their upstream regulators and are affected by aging. Table 7 shows regulators for which an activated or inhibited 
status was predicted by cognate enrichment (quantifying change by z-score > 2 and P < 1 × 10−10) for the com-
bined up and downregulation of the expression of the downstream molecules we found altered significantly in 
our arrays. This analysis predicted inhibition of a set of upstream regulators by aging under steady state condi-
tions (dexamethasone, IL4, Vegf, TGFB1, NR3C1, AGT). These regulatory processes influenced by aging point 
Upregulated genes Aging
Response to RSV
day 2 day 5 Function
Cxcl9 3.02 2.13 1.88 cytokine
Cfb 1.56 2.15 1.36 immune (other)
C4b 1.59 1.52 1.20 immune (other)
Cybb 1.61 1.44 1.62 immune (other)
Gata3 1.79 1.80 1.68 immune (other)
Downregulated genes Aging
Response to RSV
day 2 day 5 Function
Adamts15 −1.91 −1.79 −1.89 matrix
Adamts9 −1.82 −1.86 −1.69 matrix
Adamtsl2 −1.57 −1.48 −1.23 matrix
Table 3. Gene expression affected by RSV and by aging. Positive values depict fold higher expression, negative 
values depict fold reduction by aging or by response to RSV in young mice.
No Day 2 Day 5
infection post-infection post-infection
Young 13.26 11.93 18.31
Old 13.33 19.60 23.98
Table 4. Relative standard deviation. Numbers show relative standard deviation as a percentage of the mean 
expression per gene within each group.
Upregulated genes day 2 day 5 Function
C1rb 1.66 1.28 immune (other)
Dhx58 1.61 1.10 immune (other)
Ifi204 3.14 1.59 innate antiviral/IFN
Oas1a 2.09 1.27 innate antiviral/IFN
Oas2 1.99 1.42 innate antiviral/IFN
Eif2ak2 1.70 1.04 innate antiviral/IFN
Oas1g 1.68 1.16 innate antiviral/IFN
Table 5. Gene expression affected by RSV at old age only. Values depict fold higher expression in old RSV-
infected mice compared to uninfected old mice.
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at defective immune suppression via glucocorticoid receptors (dexamethasone and the glucocorticoid receptor 
NR3C1) and TGF-B.
Aging and infection by RSV are both known to involve biological processes that are part of disease. We ques-
tioned whether the profile of gene expression in the lungs that is altered by aging may indicate overlap with 
known disease profiles. To this end, we analysed enrichment by significantly regulated genes in our study for 
known biological disorders by Ingenuity (Table 8). This analysis showed that the expression profile induced by 
RSV infection in the lungs showed most resemblance with the same five diseases in young and old mice. Among 
these biological disorders, we found RSV-unrelated diseases like gastrointestinal disease, endocrine system dis-




Functionday 2 day 5 day 2 day 5
Irf7 3.74 1.50 5.63 1.49 innate antiviral/IFN
Ifi27l2a 3.88 1.25 5.56 1.22 innate antiviral/IFN
Isg15 3.49 1.50 4.78 1.40 innate antiviral/IFN
Ifit3 3.43 1.74 4.47 1.41 innate antiviral/IFN
Ifit3b 3.22 1.72 4.18 1.40 innate antiviral/IFN
Ifit1 2.69 1.43 3.56 1.41 innate antiviral/IFN
Oasl2 2.19 1.40 3.05 1.25 innate antiviral/IFN
Rsad2 2.19 1.46 3.03 1.39 innate antiviral/IFN
Zbp1 1.96 1.39 2.86 1.68 innate antiviral/IFN
Ifi44 2.14 1.37 2.68 1.05 innate antiviral/IFN
Ifit2 1.96 1.29 2.50 1.29 innate antiviral/IFN
Mx2 1.91 1.19 2.39 1.27 innate antiviral/IFN
Mx1 1.97 1.36 2.38 1.35 innate antiviral/IFN
Ifi203 1.62 1.32 2.05 1.48 innate antiviral/IFN
Ifitm3 1.68 1.14 2.01 1.12 innate antiviral/IFN
Oasl1 1.52 1.15 1.91 1.13 innate antiviral/IFN
Ifih1 1.51 1.14 1.79 1.14 innate antiviral/IFN
Irf9 1.46 1.16 1.58 1.04 innate antiviral/IFN
Lgals3bp 2.26 1.29 3.02 1.40 matrix
Timp1 1.72 1.06 1.86 −1.17 matrix
Table 6. Gene expression affected by RSV at young and old age. Positive values depict fold higher expression, 
negative values depict fold reduction.
Figure 3. RSV detected in lungs by RT Q-PCR. RSV load was quantified by RT Q-PCR on viral RNA and 
depicted as amount of viral RNA relative to the amount of RNA encoding the housekeeping gene HPRT 
detected by RT Q-PCR in the same specimen. The amount of RSV RNA was quantified by calculating the 
threshold cycle values (CT) for RSV relative to the CT values measured for HPRT using the 2ΔCT method. Figure 
shows expression in lungs at day 2 or day 5 after inoculation with RSV in young and old mice. RSV was not 
detected in RT Q-PCR on mock-inoculated lungs. *P < 0.05 (ANOVA).
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for some of these diseases that were enriched for in response to RSV, i.e. organismal injury (136 genes), immuno-
logical disease (55 molecules), and metabolic disease (49 genes). In addition, the transcriptomic profile of aging 
in lung tissue resembled processes involved in cancer (134 genes) and haematological disease (55 genes). These 
findings suggest that aging induces biological alterations in lungs that resemble injury, involve aberrations of 
metabolism, and disorders mediated by functions of the immune system that would be induced at young age only 
by exogenous pathogens like RSV.
Discussion
Our study aimed to point out molecules and previously neglected biological mechanisms in lung tissue that 
may aid in directing the focus of future research on aging-related susceptibility to infectious respiratory dis-
eases. Our findings show that aging shapes alteration of the expression of unique sets of genes in lung tissue in 
both steady state and during a response to infection with RSV. Prior to challenge with virus, aged lungs showed 
reduced expression of genes involved in extracellular matrix function and showed differential expression of genes 
indicative of uncontrolled elevation of immunological activity and injury, cancer, immunological disease and 
metabolic disease. Moreover, the first line of defence in RSV-infected lungs controls the virus less effectively at 
old age, whereas RSV appeared to induce excessive immune responses by the antiviral type-I IFN pathways in 
aged lungs. Alternatively, although RSV-induced interferon responses were higher at old age and some of the ele-
vated immune activities at old age prior to infection are part of the anti-viral response, these immune mediators 
could not effectively control RSV. These findings indicate that aging may interfere with the immune homeostatic 
regulation in a way that leaves the immune system refractory to RSV and prohibits clearing of virus. Towards 
development of preventive and therapeutic interventions, this warrants directing the focus of further research 
on susceptibility to infectious respiratory diseases at old age to the role of dysregulated inflammation in viral 
pathogenesis and the role of altered extracellular matrix functions in susceptibility to infection and the physics of 
lung disease during infection.
Studies on gene expression in lung tissue under steady state condition and upon infection with RSV have indi-
cated a wide range of aging-related alterations among broad panels of immune-related genes6,7. By analysing the 
full transcriptome, we found many other immune-relate genes and also many non-immune genes can be added 
to the spectrum of gene expressions impacted by aging, both under steady state conditions and upon inoculation 
with RSV. A substantial number of the genes we found being expressed at lower levels at old age are involved in 
constituting or remodelling of the extracellular matrix, such as genes encoding collagens and periostin (Postn). 








Table 7. Predicted inhibition of upstream regulators by aging (p < 10−10).
Aging #Molecules










Endocrine System Disorders 53
RSV old #Molecules
Organismal Injury and Abnormalities 54
Immunological Disease 39
Gastrointestinal Disease 34
Endocrine System Disorders 24
Metabolic Disease 24
Table 8. Top diseases and biological functions.
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under homeostasis. Collagens sustain the functional architecture of healthy lung tissue as they provide a major 
constituent of the extracellular matrix scaffold on which cells in the lung tissue perform their functions and which 
impacts the mechanical forces involved in breathing25. Periostin is involved in airway remodelling as it promotes 
wound repair by epithelial cells and it can also induce collagen I and III gene expression26. The matrix scaffolds 
the epithelial cells that are targeted by RSV and provides the environment needed by immune cells and antiviral 
molecules to optimally migrate in the infected lungs. Moreover, remodelling of the extracellular matrix is needed 
for the physical constitution needed to breathe optimally and to provide an optimal barrier function preventing 
entry of pathogens. When the walls of alveoli are destroyed, the air sacs coalesce, which results in airflow obstruc-
tion25 as found in chronic obstructive pulmonary disease (COPD)27. Aging impacts the breathing capacity of 
lungs and the morphology and elasticity of the lungs28–31, but most studies on aging of lung tissue address defec-
tive matrix functions in the context of non-infectious diseases such as COPD. The need of the extracellular matrix 
for immune cells to locally control infection and the effect of physical obstructions caused by RSV that may add to 
the reduced respiratory capacity in aged lungs are often neglected in studies on aging-related infectious diseases 
of the lung tissue. Downregulated matrix remodelling was a major part of all aging-regulated changes of gene 
expression and therefore indicates that, in addition to altered immune responsiveness, a dysfunctional matrix 
may have a major impact on setting the stage for increased susceptibility to disease by infection at old age. We 
cannot exclude that the downregulation of matrix genes may actually be an underestimation due to transcripts 
being diluted by genes expressed by cells of the immune system invading the lungs at old age18,32. Nonetheless, 
our data warrant more detailed studies on the role of dysfunctional remodelling of the lung matrix contributing 
to susceptibility to aging-related respiratory disease in the context of pathogenic infections.
The high expression level of immunoglobulin genes combined with the high expression of the joining chain 
(J chain) of multimeric antibodies IgA and IgM, suggests the abundance of memory B cells or plasma cells pro-
ducing IgM and mucosal IgA antibodies at old age. Indeed, in lavages of human bronchia elevated levels of IgA 
and IgM have been found at old age indicating increase of antibody producing cells in the lungs by aging29. This 
may be due to accumulation of memory B cells residing in lung tissue upon infections33 experienced over the 
years. Another explanation may be found in the increased immune activity represented in a set of genes in our 
study and found by others in elevated numbers of pulmonary lymphocytes at old age and in low-grade chronic 
inflammation, known as inflammaging18,29,34. These conditions are likely to attract immune cells into the aged 
lung tissue. Moreover, our analyses suggested downregulation of immunosuppressive upstream mechanisms 
associated with molecules like TGFB1, glucocorticoid receptor NR3C1 and Dexamethasone. This finding indi-
cates defective responsiveness to anti-inflammatory pathways that are naturally exerted by our immune system 
to prevent immune-mediated diseases may be responsible for the elevated activation status of immune cells in 
aged lung tissue. Since inflammatory conditions are involved in many aging-related diseases and frailty, it would 
be interesting to find out in future research to what extent inflammaging of the lung tissue may contribute to 
aging-related susceptibility to respiratory infections. Understanding of how elevated immune activities in lung 
tissue may contribute to dysfunctions and disease will provide targets that can be used to design treatments and 
preventive measures other than vaccines alone.
Aged lungs mounted an abundant response to RSV in innate anti-viral interferon pathways. Many genes of 
these pathways were even expressed to a higher level than in RSV-inoculated lungs at young age. Type I interfer-
ons are key to the direct innate response to a viral infection that is required to prevent further infection and spread 
of viruses. Since old mice less effectively control the viral burden while they highly expressed genes involved 
in anti-viral interferon pathways, our findings indicate that the anti-viral interferon pathways at old age may 
function less effectively and may be enhanced by higher viral loads due to dysfunctions in other anti-viral func-
tionalities at old age. Additional analyses by Ingenuity of prediction of upstream regulators indicated defective 
natural downregulation of STAT3 upon RSV infection at old age (Supplemental Table S2). Since STAT3 has been 
shown to negatively regulate the inflammatory properties of type I IFNs35, suggesting that inadequate control of 
the interferon pathway leads to abundant activation of interferon pathways by infections at old age. Alternatively, 
dysregulation of the interferon pathways by aging may also be found in the very early kinetics of response to virus. 
Several studies have shown that innate immune cells from lung mount a slower innate interferon response to virus 
within the first hours upon encounter of virus. Our analyses and studies by others focused on later time-points 
during responsiveness in the infected airways, but future research on the age dynamics of the interferon pathways 
in situ should clarify on this age-related phenomenon of the dynamics during the first day of a viral challenge. In 
addition to direct anti-viral functions, activation of the innate interferon pathways have been shown to induce 
inflammation that may harm the lung tissue36. This leads to suggest that exaggerated induction of interferon 
pathways by uncontrolled virus may drive inflammation that causes enhanced pathogenesis during an infection 
at old age. Studies have shown that anti-inflammatory treatment during RSV infection can prevent pathology 
even though these anti-inflammatory modulators diminish control of viral replication7. Altogether, these findings 
warrant thorough studies on dysregulation of the balance between anti-viral versus pro-inflammatory functions 
of interferons in disease by pulmonary infections at old age. Moreover, improving the use of anti-inflammatory 
interventions may be promising and gain focus over just the induction of stronger adaptive immune responses in 
the context of vaccination.
Induction of genes by RSV at young age that was not found at old age, indicate that aging causes loss of 
responsiveness in different molecular pathways involved in the immune responses to RSV in the lungs. Among 
these we found a set of chemokines like CXCL10 and CCL8 that regulate migration of immune cells in tissue and 
molecules such as FCGR1 and MHC-related genes that confer antigen processing and presentation to orchestrate 
specific immunity by adaptive immune cells. These processes have indeed been reported to be impaired at old age. 
However, since the group of old mice showed higher variation we cannot exclude that lack of statistically signifi-
cant induction of all these genes at old age may be due to lower statistical power in the aged animals.
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Interestingly, the inter-animal variation was comparable in uninfected young and old mice, but variation of 
responsiveness to RSV between individuals is larger in the old age group compared to the young RSV‐inoculated 
mice, indicating that the higher variation between old animals becomes apparent only upon infection with RSV. 
Notably, increased biological variation at old age is a major biological phenomenon that is now gaining more 
attention in order to better understand the processes involved in aging and hence lead to dysfunctions at old 
age37–40.
Notably, we found in lungs that aging induces expression of a set of genes that are expressed at young age only 
upon infection with RSV. Many of these have relevant functions in the immune system and suggest an antiviral 
immune status partly being active chronically, and maybe in a way that makes the immune system refractory 
to RSV. Expression of CXCL9, also known as MIG, a chemokine that attracts T cells and NK cells via the ligand 
CXCR341, may explain the chronically elevated level of these cells in aged lungs reported by others. Expression of 
CYBβ, a microbicidal protein that is part of the oxidase system of phagocytes42, also indicates elevated antimicro-
bial activity in lungs at old age. Elevated GATA3 we found in old animals may indicate enhanced activity by type 
2 T-cell responses and allergy-like lung inflammation, since GATA3 is a transcription factor that is expressed by 
Th2 cells and Type 2 innate lymphoid cells, and promotes susceptibility to allergy-like inflammation associated 
with Th2 responses43–46. However, Ingenuity analyses predicted downregulation of Th2-inducers or inhibition of 
responsiveness to these inducers (IL-4 and VEGF47) and therefore suggests regulation of GATA3-mediated effects 
other than mere propagation of Th2 functions45. CFB and C4b are molecules of the alternative complement path-
way and known to be produced in large amounts in the liver. Finding complement expression in aged lungs and 
upon RSV infection indicates that the liver may not be the sole and major organ for producing complement under 
some settings. These findings suggest that aging induces biological alterations in functions of the immune system 
that all would be induced at young age only by exogenous pathogens like RSV. Whether this is a result of dysfunc-
tional immune regulation at old age that may contribute to susceptibility or, alternatively, maybe a requirement 
for needed enhancement of immune patrol to retain sufficient immunity at old age remains to be defined.
Cotton rats are highly susceptible to infection and disease by RSV. They provide the most representative small 
animal model to study responsiveness to RSV infection, but tools that enable thorough cellular analyses and the 
number of published studies on aging in the cotton rat model are limited. Nonetheless, some of the key features 
of aging indicated by our analyses have been indicated also in this model. Our findings are in line with the limited 
number of studies on responsiveness to RSV in cotton rats, as these studies showed slower clearance of virus, 
stronger pro-inflammatory responsiveness in RSV-infected lungs, and enhanced acute responses to classical 
innate stimuli at old age7,8,39,48.
Our findings indicate multiple new directions and considerations for future research. One important consid-
eration for future studies is the notion that RSV may infect alveolar type I and type II epithelial cells at different 
rates, but may also infect immune cells like alveolar macrophages49,50. Both the cellular composition of the lungs 
and the functionality of different cell subsets may be subject to aging51,52. Therefore, future studies should reveal 
which of the different types among the alveolar cells contribute most to aging-related effects we found and how 
molecular pathways we found to be affected by aging may mechanistically interact in these alveolar cell types. 
For example, mechanistic in vitro studies with alveolar type II epithelial cells have shown that TGF-β promotes 
differentiation of these cells from type II into type I cells53. Ingenuity analyses of our data indicated hampered 
TGF-β signalling at old age, suggesting that hampered TGF-β signalling may contribute to reduced transdiffer-
entiation of alveolar cells in lungs and hence lead to altered ratio of alveolar type I and type II pneumocytes at old 
age. Moreover, it would be interesting to define the impact of RSV, or selected proteins derived from the virus, on 
regulation of inflammatory genes and extracellular matrix genes. Such future approaches based on findings like 
ours will open a new era in research on the impact of aging on susceptibility to RSV.
Differences between mouse strains, such as C57BL/6 we used or BALB/c strains used by others6, and differ-
ences between mouse and human samples may interfere with interpretations on the effect of aging on expression 
of selected genes of interest54. Nonetheless, our study indicates that research on compromised immunity to infec-
tions by aging should look beyond the defective induction and functionality of memory cells and antibodies to 
RSV at old age. Future studies should therefore address means that could improve primary barrier function in 
lungs, dysregulated innate immune responses in the lungs, and means to control exaggerated pro-inflammatory 
immune activity that contribute to pathology.
Methods
Animals. Female specific-pathogen-free (SPF) C57BL/6JRccHsd mice were obtained from Harlan 
Laboratories (Horst, The Netherlands). At the start of the experiment young mice were used at the age of 8 to 
10 weeks, old mice were used at the age of 62 to 72 weeks. The maximum life span of mice is more than the age 
within this range, but mice within this age range and even somewhat younger age have been show to express 
significant aging-related susceptibility to respiratory disease by influenza virus, RSV and SARS coronavirus55–57, 
declined immune responsiveness55,58 and a broad range of other age-related aberrations37,38. We choose to use 
mice within this age range since they would show aging-related phenomena, without the risk of losing mice 
from our analyses due to very old age37,38. Mice were kept in a 12-hour light/dark cycle under SPF and tempera-
ture-controlled conditions, and were fed ad libitum.
Ethics. All animal work was approved by the ethics committee (Dierexperimentencommissie) of RIVM 
(Rijksintituut voor Volksgezondheid en Milieu) and conducted in accordance with the Dutch national legislation 
on Animal Experimentation.
Experimental Design. Experimental procedures have been described extensively in our previous studies 
and were performed in accordance with national and our institutional guidelines5,59. In brief, young and old 
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C57BL/6 mice were inoculated intranasally with 50 µl containing an infectious dose of 106 TCID50 RSV type A2 
or mock as control, under anaesthesia by isoflurane. At day 2 and 5 after inoculation, mice were anesthetized 
with Ketamine/Xylazine, bled and sacrificed to collect lungs. Lungs were perfused with PBS to eliminate blood 
cells prior to collection of the tissue, immersed in RNAlater RNA stabilization agent (Ambion) and subsequently 
stored at −80 °C until further processing. RNA was extracted from homogenized lung tissue using the RNeasy kit 
(Qiagen). RNA concentrations were measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific). 
RNA quality was measured using the Bioanalyzer (Agilent Technologies). A total number of 28 RNA samples 
(N = 4 for uninfected groups, N = 5 for infected groups) were used for transcriptional profiling with microarrays.
Microarray analysis. RNA amplification, labelling and hybridization to microarrays was carried out at the 
Microarray Department of the University of Amsterdam, The Netherlands, according to methods described pre-
viously60. Cy3-labeled RNA samples and a Cy5-labeled common reference (made by pooling equimolar amounts 
of antisense RNA aRNA from individual samples) were hybridized to NimbleGen 12 × 135 k Mus musculus 
microarrays (Roche, Germany), containing probes for 44,170 genes with 3 spots per target probe. Each microar-
ray corresponded to labelled RNA from one individual mouse.
Briefly, 500 ng total RNA of each sample was amplified according to the Agilent QuickAmp kit manual 
(Agilent technologies). A common reference sample was made by pooling equimolar amounts of aRNA from 
individual samples. Cy3 and Cy5 monoreactive dyes (GE Healthcare) were used to label individual samples and 
the common reference sample, respectively. Labelling was performed with 10 ml of CyDye solution and incubated 
for 1 hour before the reaction was quenched by adding 5 ml 4 M hydroxylamine (Sigma-Aldrich). Purification 
was performed by using a clean-up kit (E.Z.N.A. MicroElute RNA Clean Up Kit, Omega Bio-Tek, Norcross, 
United States). The yields of amplified RNA and incorporation of CyDye were determined by using a NanoDrop 
spectrophotometer. Hybridization mixture was prepared by adding a dried mixture (1:1) of sample (Cy3) and 
common reference (Cy5) together with sample tracking control (STC, Roche NimbleGen) and hybridization 
cocktail (NimbleGen Arrays User’s Guide – Gene Expression Arrays Version 5.0, Roche NimbleGen). Samples 
were incubated for 5 min. at 95 °C and 5 min. at 42 °C. Hybridization was performed by loading a sample onto 
a microarray. Hybridization was performed with a NimbleGen Hybridization System 4 (Roche NimbleGen) for 
20 hours at 42 °C. After washing (NimbleGen Arrays User’s Guide – Gene Expression Arrays Version 5.0), slides 
were scanned in an ozone-free room with a microarray scanner (Agilent DNA microarray scanner G2565CA, 
Agilent Technologies). Feature extraction was performed with NimbleScan v2.5 (Roche NimbleGen) resulting in 
a table containing individual probe signal intensities for both dyes.
Complete raw and normalized microarray data and their MIAME compliant metadata from this publication 
have been submitted to the GEO database (www.ncbi.nlm.nih.gov/geo) and assigned the identifier GSE111947.
Data analysis. Quality control on raw microarray data was performed by means of Cy3-Cy5 scatter plots and 
by comparing signal average and distribution across slides. All slides passed quality control. Data for gene-coding 
probes were normalized in R (www.r-project.org), by using a four step approach60 consisting of: (1) natural 
log-transformation, (2) quantile normalization of all scans, (3) correcting the sample spot signal for its corre-
sponding reference spot signal and (4) averaging data from replicate probe spots. This resulted in normalized data 
for 44170 probes, which was used for further statistical analysis in R and Microsoft Excel.
Differentially expressed genes were identified by using ANOVA to compare (a) groups of young mice (unin-
fected, 2 days, 5 days post infection (p.i.)); (b) groups of old mice (uninfected, 2 days, 5 days p.i.); (c) uninfected 
young vs old mice. Probes were considered differentially expressed if they met the following two criteria for at 
least one of the above comparisons: (i) a p-value < 0.001 (determined by ANOVA), which for this study cor-
responds to a False discovery rate (FDR) < 5% when accounting for multiple testing; and (ii) an absolute fold 
change > 1.5 (up- or down-regulated). If multiple probes corresponding to the same gene were significant, their 
data were averaged to remove redundancy in further analyses. Fold changes were calculated as the average gene 
expression levels of three mice per group compared to the respective control group. Variation within groups was 
expressed as relative standard deviation (also known as the coefficient of variation) and calculated as the square 
root of the average variance across the expression data per gene within each group. The complete set of all signif-
icantly regulated genes can be found in a supplemental file (Table S1) accompanying this paper.
Differences in gene expression were visualized by Principal Component Analysis (PCA) and by heatmaps. 
Functional annotation with over-representation analysis of differentially expressed genes was carried out by using 
DAVID24. Genes with similar functional annotation based on Gene Ontology (GO), Kyoto Encyclopedia of Genes 
and Genomes (KEGG), or UniProt, were combined into functional umbrella terms. Additionally, differentially 
expressed genes were imported in Ingenuity Pathway Analysis (Qiagen), Build version: 463341 M, Content ver-
sion: 42012434 (Release Date: 2017-12-07), for prediction of upstream regulators as well as comparison with 
diseases and biological functions.
Viral load. RSV was quantified in the lungs of mice by real-time quantitative PCR (RT Q-PCR) for detec-
tion of RNA copies of RSV A as described before5, using the 7500 Fast real-time PCR system (Thermo Fisher 
Scientific). All PCRs were done on equal amounts of input RNA, calculated from the total RNA concentrations 
measured in each sample. Expression of the housekeeping gene hypoxanthine phosphoribosyltransferase (Hprt) 
was used as an endogenous reference, and confirmed equal amounts of total RNA used as input for all different 
samples. Threshold cycles (CT) values were used for quantification of RNA copies of RSV or HPRT during runs 
of 40 PCR cycles. The amount of RSV RNA was quantified by calculating the CT values for RSV relative to the CT 
values measured for Hprt using the 2ΔCT method.
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Real time Q-PCR validation. To validate the gene expression changes found by microarray analysis, we 
performed real time quantitative PCR (RT Q-PCR). For this purpose, ten genes were chosen that represent 
the various pathways affected, namely innate interferon (IFN)-mediated antiviral function (Ifit1, Mx1, Mx2), 
cytokines (Ccl8, Cxcl9, Cxcl10), antigen processing and presentation (B2m), other immune function (Saa3), and 
matrix constitution (Col1a2, Sparc). All reagents, methods and equipment were obtained from Thermo Fisher 
Scientific. TaqMan gene expression assay IDs used are given in Supplemental Table S3. Assays for Hprt (custom 
made5) and Polr2a (Mm00839502_m1) were included as endogenous controls. Threshold cycles were automat-
ically derived from the amplification plots constructed of the fluorescence signals by the 7500 Fast system SDS 
software. The average of the Hprt and Polr2a level per sample was used to normalize the expression of the other 
genes. Relative quantification of the mRNA copies in the samples compared to that of the young mock-infected 
group was performed by the comparative threshold cycle (2−ΔΔCT) method using Microsoft Excel.
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